Madeline Lewis
Nurse Practitioner · Lexington, KYNPI 1851054787
Payments from drug & device makers
Across 249 payments — averaging $16.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$678
- Corium, LLC$497
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$367
- Ironshore Pharmaceuticals Inc.$316
- Alkermes, Inc.$272
- Otsuka America Pharmaceutical, Inc.$226
- plus $2K from 26 others
What the payments were for
- Food & beverage$4,225100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $678 |
| Corium, LLC | 23 | $497 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $367 |
| Ironshore Pharmaceuticals Inc. | 19 | $316 |
| Alkermes, Inc. | 11 | $272 |
| Otsuka America Pharmaceutical, Inc. | 11 | $226 |
| Teva Pharmaceuticals USA, Inc. | 10 | $196 |
| Almatica Pharma LLC | 9 | $189 |
| Neurocrine Biosciences, Inc. | 9 | $185 |
| Axsome Therapeutics, Inc. | 8 | $181 |
| Vanda Pharmaceuticals Inc. | 11 | $174 |
| Johnson & Johnson(2 entities) | 7 | $136 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $112 |
| Lundbeck LLC | 5 | $104 |
| Supernus Pharmaceuticals, Inc. | 6 | $89 |
| Tris Pharma Inc | 3 | $64 |
| Lilly USA, LLC | 4 | $55 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Exact Sciences | 3 | $44 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Sage Therapeutics, LLC | 2 | $39 |
| Novo Nordisk | 2 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| Bayer | 1 | $22 |
| Tonix Medicines, Inc. | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $15 |
| Novartis | 1 | $15 |
| Dexcom, Inc. | 1 | $14 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $13 |
| GSK | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,225 in reported general payments places this provider in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| VraylarCariprazine Hcl | 75 | $110,222 |
| IngrezzaValbenazine Tosylate | 11 | $91,466 |
| Invega SustennaPaliperidone Palmitate | 16 | $56,539 |
| CaplytaLumateperone Tosylate | 23 | $36,301 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 153 | $13,761 |
| Aripiprazole | 89 | $9,842 |
| Jornay PmMethylphenidate Hcl | 14 | $6,257 |
| Bupropion XlBupropion Hcl | 205 | $6,096 |
| Adderall XrDextroamphetamine/Amphetamine | 13 | $3,172 |
| Atomoxetine Hcl | 15 | $3,018 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 76 | $2,975 |
| Buspirone Hcl | 229 | $2,178 |
| Duloxetine Hcl | 75 | $2,012 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 83 | $1,947 |
| Quetiapine Fumarate | 100 | $1,868 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieVraylar | $678 | $110,22275 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $185 | $91,46611 claims |
| Johnson & JohnsonInvega Sustenna | $136 | $56,53916 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $367 | $36,30123 claims |
| Ironshore Pharmaceuticals Inc.Jornay Pm | $316 | $6,25714 claims |
| Almatica Pharma LLCSertraline Hcl | $189 | $37765 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Lexington
- Rachael BradfordLexington$447K
- Juawanna SchullerLexington$26K
- Jessica SchorckLexington$26K
- Amelia HendricksonLexington$22K
- Megan CollettLexington$13K
- Amy NydamLexington$11K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.